Seizure and Epilepsy
Updated UKMLA guide to seizures and epilepsy, including generalised tonic clonic, atonic, myoclonic, absence, and focal seizures.
Overview and Definition
| Term | Definition |
|---|---|
| Seizure | A seizure is a clinical presentation, not a disease or condition. It is a transient episode of signs or symptoms caused by abnormal, excessive or synchronous neuronal activity in the brain. |
| Status epilepticus |
|
| Epilepsy | Epilepsy is characterised by an enduring tendency to have epileptic seizures.
According to the ILAE, epilepsy is defined by the presence of ANY of the following
Exam note For exam purposes, the most important definition to remember is: epilepsy = at least 2 unprovoked seizures occurring >24 hours apart. A single acute symptomatic seizure due to a reversible trigger ≠ epilepsy (e.g. due to hypoglycaemia, alcohol withdrawal or severe hyponatraemia) |
Causes
Epilepsy is one cause of seizures, but not all seizures are due to epilepsy.
Epilepsy refers to an enduring tendency to have epileptic seizures. Therefore, epilepsy is one possible cause of recurrent unprovoked seizures, but not every seizure is due to epilepsy.
Seizure Causes
Seizures can be broadly divided into provoked and unprovoked seizures
- A provoked seizure, also known as an acute symptomatic seizure, occurs due to an acute trigger that temporarily lowers the seizure threshold
- An unprovoked seizure occurs without an immediate reversible trigger and may suggest an underlying tendency to recurrent seizures, such as epilepsy
Causes of seizures can be remembered using the VITAMIN C mnemonic: [Ref]
| Category | Specific causes |
|---|---|
| Vascular |
|
| Infection |
|
| Trauma |
|
| Autoimmune / inflammatory |
|
| Metabolic |
|
| Intoxication / iatrogenic / withdrawal |
|
| Neoplasm |
|
| Congenital |
|
Epilepsy Causes
Common causes include:
- Structural – previous stroke, previous TBI, brain tumour, vascular malformation, cortical malformation, neurocutaneous syndrome (tuberous sclerosis, Sturge-Weber syndrome, neurofibromatosis)
- Genetic – epilepsy syndromes (e.g. juvenile myoclonic epilepsy), genetic generalised epilepsies
- Infectious – chronic CNS infection, post-acute CNS infection, complicated febrile seizures (increases risk of epilepsy)
- Metabolic – inherited metabolic disorders (e.g. GLUT1 deficiency, PKU), porphyria
- Immune / autoimmune – autoimmune encephalitis-associated epilepsy
- Unknown
The same broad disease category can cause seizures in different ways depending on timing.
- For example, an acute stroke may cause an acute symptomatic seizure, whereas a previous stroke may leave an epileptogenic scar that causes later unprovoked seizures or epilepsy
- Similarly, acute hyponatraemia can provoke a seizure, whereas a persistent inherited metabolic disorder may be contributing to epilepsy
Types and Clinical Features
Generalised Seizures
Generalised seizures are characterised by abnormal neuronal activity originating from both hemispheres
Important types of generalised seizures:
| Type | Clinical features |
|---|---|
| Generalised tonic-clonic seizure (also known as convulsive seizure and grand mal) | Motor symptoms occur in the following order of sequence, usually last ~1-3 min:
The presence of the following features is strongly suggestive of generalised tonic-clonic seizure
|
| Tonic seizure | Bilateral increased tone lasting 3 sec to min
Often occurs from sleep, may occur in series overnight, and awareness is impaired |
| Clonic seizure | Bilateral, sustained rhythmic jerking with LOC |
| Atonic seizure | Classic “drop attack”
|
| Myoclonic seizure | May affect a body part or the entire body
Awareness may be retained |
| Absence seizure | Absence seizure is a generalised non-motor seizure (all the above-mentioned types are motor)
Rapid recovery with amnesia, with NO post-ictal phase If an “absence” lasts >45 seconds or has a post-ictal phase, consider a focal seizure |
Focal Seizures (Old: Partial Seizures)
Focal seizures are characterised by abnormal neuronal activity originating from a single hemisphere
Shared features of focal seizures:
- Awareness may be preserved or impaired
- Clinical features depend on the affected brain region
- Amnesia may occur (esp. if awareness is impaired)
- Post-ictal symptoms may occur (esp. if awareness is impaired)
The ILAE classification system breaks down focal seizures into 2 tiers: [Ref]
| 1. Level of awareness |
|
| 2. Type of onset features |
|
Focal seizure may progress to bilateral tonic-clonic seizure (generalisation)
Lobar localisation clues (traditionally how focal seizures are classified):
| Lobe | Typical clues |
|---|---|
| Temporal |
Classically caused by:
|
| Frontal |
|
| Parietal |
|
| Occipital |
|
Complications
Risk of progression to status epilepticus
Long-term complications
- Reduced quality of life
- Mental health comorbidities (depression, anxiety, psychosis are more common in those with epilepsy + higher risk of dying from suicide)
- Accidents during seizures (e.g. drowning, fractures, falls, RTAs, head injury, choking)
- Sudden unexpected death in epilepsy (SUDEP)
- Defined as sudden, unexpected, unwitnessed, non-traumatic, non-drowning death of a person with epilepsy, with or without a seizure
- Underlying mechanism: early postictal, centrally mediated, severe alteration of respiratory and cardiac function induced by generalised tonic-clonic seizures
- ~60% of cases occur during sleep
- Most common cause of epilepsy-related death in young adults with uncontrolled epilepsy
Developmental and cognitive problems are mainly seen in children and young people
Assessment and Work-Up
Referral Criteria
Refer urgently (appointment within 2 weeks) if:
- After a first seizure, or
- Seizure recurrence after a period of remission
In the UK, urgent appointments in the context of new-onset seizures are scheduled in first seizure clinics (FSCs).
Investigation and Diagnosis
Standard Workup
A standard workup for suspected epilepsy includes:
| Test | Notes |
|---|---|
| 12-lead ECG | To identify arrhythmias or other potential causes of cardiac syncope (which can mimic a seizure) |
| Blood tests (including glucose and electrolyte levels) | To exclude hypoglycaemia and other electrolyte causes of seizure |
| Neuroimaging |
|
| Electroencephalogram (EEG) |
|
Additional Specialised Testing
| Test | Indications |
|---|---|
| Genetic testing (whole genome sequencing) |
|
| Antibody testing (e.g. anti-NMDA, anti-GABA) |
|
Management
For acute seizure management, including first aid, initial hospital assessment and management, status epilepticus, see the Acute Seizure (Including Status Epilepticus) article.
Conservative / General Management
Advise on the following:
- Identify and avoid precipitating factors that may provoke seizures (e.g. sleep deprivation, flashing lights, alcohol consumption, physical exertion)
- Adapt activities of daily living to minimise accidents during seizures
- Shower instead of having baths
- Only swim / participate water sports under supervision
- Avoid working at heights
- Consider night-time supervision (for those who have seizures during sleep and at higher risk of epilepsy-related death)
Seizure / epilepsy and driving (key important DVLA guidance):
| Licence type | DVLA guide |
|---|---|
| Group 1 (car, motorbike) |
For further guidance (e.g. seizure due to medication / dose change, seizure while asleep, seizures that do not affect consciousness), see this link |
| Group 2 (bus, coach, lorry) | Regardless, stop driving immediately + license to be revoked
Reapplication eligibility:
|
Pharmacological Management (Anti-Epileptics)
When to Start Anti-Epileptic Drugs
Consider starting treatment after a first unprovoked seizure if any of the following:
- Neurological deficit on examination
- Abnormal EEG (unequivocal epileptic activity)
- Structural abnormality on neuroimaging
- Patient / family / carers consider risk of further seizures unacceptable
Management Principles
Use monotherapy whenever possible
If 1st line monotherapy is unsuccessful → attempt monotherapy with a different medication
- Increase the dose of the second medicine slowly while maintaining the dose of the first medicine
- If the second medicine is successful, slowly taper off the dose of the first medicine
- If still unsuccessful → consider add-on therapy
Choice of Anti-Epileptic Drugs
For exam purposes and non-specialist practice, the key points are to learn the 1st line medications and any contraindications and understand that, if initial monotherapy is ineffective, clinicians usually switch to an alternative monotherapy before adding further medication. Anti-seizure medications should be started under specialist guidance.
Therefore, further 2nd line / add-on treatment options outlined by NICE are omitted here.
1st line anti-epileptic drugs for various types of seizures:
| Seizure Type | 1st line medication |
|---|---|
| Generalised tonic-clonic seizure | Monotherapy of:
If unsuccessful, switch to another 1st line option |
| Focal seizure | Monotherapy of:
|
| Absence seizure | Monotherapy of ethosuximide
Do NOT use the following, as they may exacerbate seizures in absence seizure:
|
| Myoclonic seizure | Monotherapy of:
Do NOT use the following, as they may exacerbate seizures in myoclonic seizure:
|
| Tonic or atonic seizure | Monotherapy of:
|
MHRA advises that sodium valproate should NOT be started for the first time in BOTH males AND females who are <55 y/o (this is because valproate is highly teratogenic).
- For exam purposes, it might be helpful to think that the other listed medications are generally 1st line, instead of sodium valproate
- However, it would be incorrect to say that sodium valproate is no longer 1st line for epilepsy, as it is still a 1st line option but is largely limited by the MHRA safety measures and precautionary advice for sodium valproate
- If someone is already taking sodium valproate (and it is contraindicated) → advise NOT to discontinue sodium valproate unless instructed by a specialist
Topiramate is contraindicated and should not be used in girls and women of childbearing potential unless a pregnancy prevention programme is in place
Discontinuing Anti-Epileptic Drugs
Only consider discontinuing anti-epileptic drugs after 2 years of seizure-free
- An individualised assessment by a specialist should be done to determine risk of seizure recurrence if medications are discontinued
Anti-epileptic drugs should be stopped gradually:
- For most medicines: over at least 3 months
- For benzodiazepines and barbiturates, this would typically be over a longer period to reduce the risk of drug-related withdrawal symptoms
- For those who take multiple medications: discontinue one at a time
Epilepsy can be defined as resolved if the patient has remained seizure-free for the past 10 years, with no antiseizure medication for at least the past 5 years.
References
Related Articles
Acute Seizure (Including Status Epilepticus)
Raised Intracranial Pressure (ICP)
Cerebral Venous Sinus Thrombosis (CVST)
Hypertension in Pregnancy (Gestational Hypertension, Pre-Eclampsia, and Eclampsia)